Position statement presents the 1-hour post-load plasma glucose (1-h PG) test as a more sensitive and practical method to screen for IH and type 2 diabetes in people at...
-
The annual European Association for the Study of Diabetes (EASD) conference in Hamburg on 2-6 October brought together global experts to share findings in diabetes research.
-
Clinical trial findings for new survodutide and semaglutide treatments and promising phase 2 retatrutide results.
-
Updates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.